Javascript must be enabled to continue!
Rac1 Regulates Myosin II Phosphorylation Through Regulation of Myosin Light Chain Phosphatase
View through CrossRef
Phosphorylation of regulatory light chain (MLC) activates myosin II, which enables it to promote contractile and motile activities of cells. We report here a novel signaling mechanism that activates MLC phosphorylation and smooth muscle contraction. Contractile agonists activated Rac1, and Rac1 inhibition diminished agonist‐induced MLC phosphorylation, thus inhibiting smooth muscle contraction. Rac1 inhibits the activity of MLC phosphatase (MLCP) but not that of MLC kinase, through a phosphatase that targets MYPT1 (a regulatory subunit of MLCP) and CPI‐17 (a MLCP specific inhibitor) rather than through the RhoA‐Rho dependent kinase (ROCK) pathway. Rac1 inhibition decreased the activity of protein kinase C (PKC), which also contributes to the change in CPI‐17 phosphorylation. We propose that activation of Rac1 increases the activity of PKC, which increases the phosphorylation of CPI‐17 and MYPT1 by inhibiting the phosphatase that targets these proteins, thereby decreasing the activity of MLCP and increasing phosphorylation of MLC. Our results suggest that Rac1 coordinates with RhoA to increase MLC phosphorylation by inactivation of CPI‐17/MYPT1 phosphatase, which decreases MLCP activity thus promoting MLC phosphorylation and cell contraction. J. Cell. Physiol. 230: 1352–1364, 2015. © 2014 Wiley Periodicals, Inc., A Wiley Company
Title: Rac1 Regulates Myosin II Phosphorylation Through Regulation of Myosin Light Chain Phosphatase
Description:
Phosphorylation of regulatory light chain (MLC) activates myosin II, which enables it to promote contractile and motile activities of cells.
We report here a novel signaling mechanism that activates MLC phosphorylation and smooth muscle contraction.
Contractile agonists activated Rac1, and Rac1 inhibition diminished agonist‐induced MLC phosphorylation, thus inhibiting smooth muscle contraction.
Rac1 inhibits the activity of MLC phosphatase (MLCP) but not that of MLC kinase, through a phosphatase that targets MYPT1 (a regulatory subunit of MLCP) and CPI‐17 (a MLCP specific inhibitor) rather than through the RhoA‐Rho dependent kinase (ROCK) pathway.
Rac1 inhibition decreased the activity of protein kinase C (PKC), which also contributes to the change in CPI‐17 phosphorylation.
We propose that activation of Rac1 increases the activity of PKC, which increases the phosphorylation of CPI‐17 and MYPT1 by inhibiting the phosphatase that targets these proteins, thereby decreasing the activity of MLCP and increasing phosphorylation of MLC.
Our results suggest that Rac1 coordinates with RhoA to increase MLC phosphorylation by inactivation of CPI‐17/MYPT1 phosphatase, which decreases MLCP activity thus promoting MLC phosphorylation and cell contraction.
J.
Cell.
Physiol.
230: 1352–1364, 2015.
© 2014 Wiley Periodicals, Inc.
, A Wiley Company.
Related Results
A Direct CLIC5A/Ezrin Interaction Enables CLIC5A‐Dependent Rac1 Activation
A Direct CLIC5A/Ezrin Interaction Enables CLIC5A‐Dependent Rac1 Activation
Introduction
The CLIC (Chloride Intracellular Channel) protein CLIC5A is a component of the ezrin/podocalyxin/actin complex in kidney pod...
The Small GTPase Rac1 Increases Cell Surface Stiffness and Enhances 3D Migration Into Extracellular Matrices
The Small GTPase Rac1 Increases Cell Surface Stiffness and Enhances 3D Migration Into Extracellular Matrices
AbstractMembrane ruffling and lamellipodia formation promote the motility of adherent cells in two-dimensional motility assays by mechano-sensing of the microenvironment and initia...
Rac1 as a Potential Pharmacodynamic Biomarker for Thiopurine Therapy in Inflammatory Bowel Disease
Rac1 as a Potential Pharmacodynamic Biomarker for Thiopurine Therapy in Inflammatory Bowel Disease
Background:
Azathioprine and mercaptopurine (MP) are effective in treating patients with inflammatory bowel disease (IBD). Immunosuppressive effects of thiopurines invo...
Rac1 contributes to brain connectivity impairments and neuropsychiatric disorders in Tuberous Sclerosis Complex
Rac1 contributes to brain connectivity impairments and neuropsychiatric disorders in Tuberous Sclerosis Complex
Abstract
Tuberous sclerosis complex (TSC) is a neurodevelopmental disorder caused by inactivating mutations in the
TSC1
...
Role of myosin II activity and the regulation of myosin light chain phosphorylation in astrocytomas
Role of myosin II activity and the regulation of myosin light chain phosphorylation in astrocytomas
AbstractThe generation of contractile force mediated by actin‐myosin interactions is essential for cell motility. Myosin activity is promoted by phosphorylation of myosin light cha...
Studies of Novel Cytoskeletal Regulatory Proteins that are Involved in Abiotic Stress Signaling
Studies of Novel Cytoskeletal Regulatory Proteins that are Involved in Abiotic Stress Signaling
In the original proposal we planned to focus on two proteins related to the actin cytoskeleton: TCH2, a touch-induced calmodulin-like protein which was found by us to interact with...
Abstract 432: The noncanonical mechanism of metabolic enzyme LDHA in cancer progression
Abstract 432: The noncanonical mechanism of metabolic enzyme LDHA in cancer progression
Abstract
Metabolic reprogramming is a hallmark of cancer cells and a key contributor to cancer progression, which is a promising target for cancer therapies. The enh...
Restoration of Cardiac Myosin Light Chain Kinase Ameliorates Systolic Dysfunction by Reducing Superrelaxed Myosin
Restoration of Cardiac Myosin Light Chain Kinase Ameliorates Systolic Dysfunction by Reducing Superrelaxed Myosin
Background:
Cardiac-specific myosin light chain kinase (cMLCK), encoded by
MYLK3
, regulates cardiac contractility through ph...

